Access the full text.
Sign up today, get DeepDyve free for 14 days.
Emad Al-Absi, F. Farrokhyar, Rajrish Sharma, Kaitlyn Whelan, T. Corbett, M. Patel, M. Ghert (2010)
A Systematic Review and Meta-Analysis of Oncologic Outcomes of Pre- Versus Postoperative Radiation in Localized Resectable Soft-Tissue SarcomaAnnals of Surgical Oncology, 17
J. Poleszczuk, K. Luddy, Sotiris Prokopiou, M. Robertson-Tessi, E. Moros, M. Fishman, J. Djeu, S. Finkelstein, H. Enderling (2016)
Abscopal Benefits of Localized Radiotherapy Depend on Activated T-cell Trafficking and Distribution between Metastatic Lesions.Cancer research, 76 5
R. Walker, J. Poleszczuk, S. Pilon-Thomas, Sungjune Kim, A. Anderson, B. Czerniecki, L. Harrison, E. Moros, H. Enderling (2018)
Immune interconnectivity of anatomically distant tumors as a potential mediator of systemic responses to local therapyScientific Reports, 8
J. Miccio, O. Oladeru, Jie Yang, Yaqi Xue, M. Choi, Yue Zhang, H. Yoon, S. Ryu, A. Stessin (2016)
Neoadjuvant vs. adjuvant treatment of Siewert type II gastroesophageal junction cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.Journal of gastrointestinal oncology, 7 3
N. Leroi, N. Sounni, Eva Overmeire, S. Blacher, R. Marée, J. Ginderachter, F. Lallemand, E. Lenaerts, P. Coucke, A. Noel, P. Martinive (2015)
The timing of surgery after neoadjuvant radiotherapy influences tumor dissemination in a preclinical modelOncotarget, 6
Julian Hong, James Murphy, Samuel Wang, A. Koong, D. Chang (2013)
Chemoradiotherapy Before and After Surgery for Locally Advanced Esophageal Cancer: A SEER-Medicare AnalysisAnnals of Surgical Oncology, 20
R. Sauer, H. Becker, W. Hohenberger, C. Rödel, C. Wittekind, R. Fietkau, P. Martus, J. Tschmelitsch, E. Hager, C. Hess, J. Karstens, T. Liersch, H. Schmidberger, R. Raab (2004)
Preoperative versus postoperative chemoradiotherapy for rectal cancer.The New England journal of medicine, 351 17
E. Reits, J. Hodge, C. Herberts, T. Groothuis, M. Chakraborty, Elizabeth K.Wansley, K. Camphausen, R. Luiten, A. Ru, J. Neijssen, A. Griekspoor, Elly Mesman, F. Verreck, H. Spits, J. Schlom, P. Veelen, J. Neefjes (2006)
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapyThe Journal of Experimental Medicine, 203
R. Walker, H. Enderling (2015)
From concept to clinic: mathematically informed immunotherapybioRxiv
S. Rockwell, I. Dobrucki, Eugene Kim, S. Marrison, Van Vu (2009)
Hypoxia and radiation therapy: past history, ongoing research, and future promise.Current molecular medicine, 9 4
Tewart, Nderson, Ohn, RYANt, Ichard, M. G., Argolese, Elvin, Eutsch, Dwin, F. R., Isher, Ong, H, Yeon, Eong, Orman, Olmark (2002)
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.The New England Journal of Medicine, 347
Miccio JA, Oladeru OT, Yang J
Neoadjuvant vs
S. Formenti, S. Demaria (2013)
Combining radiotherapy and cancer immunotherapy: a paradigm shift.Journal of the National Cancer Institute, 105 4
F. Teng, D. Mu, Xiangjiao Meng, L. Kong, Hui Zhu, Sujing Liu, Jianbo Zhang, Jinming Yu (2015)
Tumor infiltrating lymphocytes (TILs) before and after neoadjuvant chemoradiotherapy and its clinical utility for rectal cancer.American journal of cancer research, 5 6
J. Poleszczuk, H. Enderling (2018)
The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor ImmunityInternational Journal of Molecular Sciences, 19
J. Poleszczuk, K. Luddy, Lu Chen, Jae Lee, L. Harrison, B. Czerniecki, H. Soliman, H. Enderling (2017)
Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survivalBreast Cancer Research : BCR, 19
B. O'Sullivan, A. Davis, R. Turcotte, R. Bell, C. Catton, P. Chabot, J. Wunder, Rita Kandel, K. Goddard, A. Sadura, J. Pater, B. Zee (2002)
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trialThe Lancet, 359
S. Formenti, S. Demaria (2009)
Systemic effects of local radiotherapy.The Lancet. Oncology, 10 7
M. Dewan, Ashley Galloway, N. Kawashima, J. Dewyngaert, J. Babb, S. Formenti, S. Demaria (2009)
Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti–CTLA-4 AntibodyClinical Cancer Research, 15
R. Vatner, B. Cooper, C. Vanpouille-Box, S. Demaria, S. Formenti (2014)
Combinations of Immunotherapy and Radiation in Cancer TherapyFrontiers in Oncology, 4
R. Sachs, P. Hahnfeld, D. Brenner (1997)
The link between low-LET dose-response relations and the underlying kinetics of damage production/repair/misrepair.International journal of radiation biology, 72 4
L. Pillis, A. Radunskaya, C. Wiseman (2005)
A Validated Mathematical Model of Cell-Mediated Immune Response to Tumor GrowthCancer Research, 65
S. Demaria, S. Formenti (2013)
Radiotherapy Effects on Anti-Tumor Immunity: Implications for Cancer TreatmentFrontiers in Oncology, 3
A. Lanzavecchia, F. Sallusto (2000)
Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells.Science, 290 5489
K. Prise, J. O’Sullivan (2009)
Radiation-induced bystander signalling in cancer therapyNature Reviews Cancer, 9
D., R., Cox
Regression Models and Life-Tables
H. Hatzikirou, J. Alfonso, S. Muhle, C. Stern, Siegfried Weiss, M. Meyer-Hermann (2015)
Cancer therapeutic potential of combinatorial immuno- and vasomodulatory interventionsJournal of The Royal Society Interface, 12
C. Creutzberg, W. Putten, C. Wárlám-Rodenhuis, A. Bergh, K. Winter, P. Koper, M. Lybeert, A. Slot, L. Lutgens, M. Kroese, H. Beerman, M. Lent (2004)
Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 7
William Dewey, C. Ling, R. Meyn (1995)
Radiation-induced apoptosis: relevance to radiotherapy.International journal of radiation oncology, biology, physics, 33 4
Sotiris Prokopiou, E. Moros, J. Poleszczuk, J. Caudell, J. Torres-Roca, K. Latifi, Jae Lee, R. Myerson, L. Harrison, H. Enderling (2015)
A proliferation saturation index to predict radiation response and personalize radiotherapy fractionationRadiation Oncology (London, England), 10
S. Roth, W. Audretsch, H. Bojar, I. Lang, R. Willers, W. Budach (2010)
Retrospective Study of Neoadjuvant Versus Adjuvant Radiochemotherapy in Locally Advanced Noninflammatory Breast CancerStrahlentherapie und Onkologie, 186
P. Kaur, A. Asea (2012)
Radiation-induced effects and the immune system in cancerFrontiers in Oncology, 2
R. Eftimie, Cicely Macnamara, J. Dushoff, J. Bramson, D. Earn (2016)
Bifurcations and Chaotic Dynamics in a Tumour-Immune-Virus SystemMathematical Modelling of Natural Phenomena, 11
A. d’Onofrio (2005)
A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferencesPhysica D: Nonlinear Phenomena, 208
El-Monim HA, El-Baradie MM, Younis A
A prospective randomized trial for postoperative vs
I. Ciernik, P. Romero, J. Berzofsky, D. Carbone (1999)
Ionizing radiation enhances immunogenicity of cells expressing a tumor-specific T-cell epitope.International journal of radiation oncology, biology, physics, 45 3
R. Eftimie, J. Bramson, D. Earn (2011)
Interactions Between the Immune System and Cancer: A Brief Review of Non-spatial Mathematical ModelsBulletin of Mathematical Biology, 73
H. Enderling, D. Park, L. Hlatky, P. Hahnfeldt (2009)
The Importance of Spatial Distribution of Stemness and Proliferation State in Determining Tumor RadioresponseMathematical Modelling of Natural Phenomena, 4
G. Frykholm, B. Glimelius, L. Påhlman (1993)
Preoperative or postoperative irradiation in adenocarcinoma of the rectum: Final treatment results of a randomized trial and an evaluation of late secondary effectsDiseases of the Colon & Rectum, 36
Steve Lee, M. Leu, J. Smathers, W. McBride, R. Parker, H. Withers (1995)
Biologically effective dose distribution based on the linear quadratic model and its clinical relevanceInternational Journal of Radiation Oncology Biology Physics, 33
H. Hatzikirou, Juan Alfonso, S. Leschner, S. Weiss, M. Meyer-Hermann (2017)
Therapeutic Potential of Bacteria against Solid Tumors.Cancer research, 77 7
A. Reppas, Jcl Alfonso, H. Hatzikirou (2015)
In silico tumor control induced via alternating immunostimulating and immunosuppressive phasesVirulence, 7
E. Golden, L. Apetoh (2015)
Radiotherapy and immunogenic cell death.Seminars in radiation oncology, 25 1
R. Serre, F. Barlesi, X. Muracciole, D. Barbolosi (2018)
Immunologically effective dose: a practical model for immuno-radiotherapyOncotarget, 9
R. Serre, S. Benzekry, L. Padovani, C. Meille, N. André, J. Ciccolini, F. Barlesi, X. Muracciole, D. Barbolosi (2016)
Mathematical Modeling of Cancer Immunotherapy and Its Synergy with Radiotherapy.Cancer research, 76 17
K. Schnarr, I. Dayes, J. Sathya, D. Boreham (2007)
Individual Radiosensitivity and its Relevance to Health PhysicsDose-Response, 5
C. Belka, P. Marini, W. Budach, K. Schulze-Osthoff, F. Lang, E. Gulbins, M. Bamberg (1998)
Radiation-induced apoptosis in human lymphocytes and lymphoma cells critically relies on the up-regulation of CD95/Fas/APO-1 ligand.Radiation research, 149 6
S. Benzekry, Clare Lamont, D. Barbolosi, L. Hlatky, P. Hahnfeldt (2017)
Mathematical modeling of tumor-tumor distant interactions supports a systemic control of tumor growthbioRxiv
J. Fowler (1989)
The linear-quadratic formula and progress in fractionated radiotherapy.The British journal of radiology, 62 740
Anastasios Matzavinos, M. Chaplain, V. Kuznetsov (2004)
Mathematical modelling of the spatio-temporal response of cytotoxic T-lymphocytes to a solid tumour.Mathematical medicine and biology : a journal of the IMA, 21 1
A. Lugade, J. Moran, S. Gerber, R. Rose, J. Frelinger, E. Lord (2005)
Local Radiation Therapy of B16 Melanoma Tumors Increases the Generation of Tumor Antigen-Specific Effector Cells That Traffic to the Tumor1The Journal of Immunology, 174
M. Koshy, O. Goloubeva, M. Suntharalingam (2011)
Impact of neoadjuvant radiation on survival in stage III non-small-cell lung cancer.International journal of radiation oncology, biology, physics, 79 5
V. Kuznetsov, G. Knott (2001)
Modeling tumor regrowth and immunotherapyMathematical and Computer Modelling, 33
Juan Alfonso, N. Jagiella, L. Núñez, M. Herrero, D. Drasdo (2014)
Estimating Dose Painting Effects in Radiotherapy: A Mathematical ModelPLoS ONE, 9
Hassan El-Monim, M. El-Baradie, A. Younis, Y. Ragab, A. Labib, I. El-Attar (2013)
A prospective randomized trial for postoperative vs. preoperative adjuvant radiotherapy for muscle-invasive bladder cancer.Urologic oncology, 31 3
Mariana Guerrero, X. Li (2003)
Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planningPhysics in Medicine & Biology, 48
Daniel Ho, K. Imai, Gary King, E. Stuart (2011)
MatchIt: Nonparametric Preprocessing for Parametric Causal InferenceJournal of Statistical Software, 42
D. Bui, James Yu (2015)
Trends in Adjuvant and Neoadjuvant Radiotherapy for Cancer Treatment From 1973 to 2011The Cancer Journal, 21
Y.-F. Cui, Y.-B. Gao, Hong Yang, C. Xiong, G. Xia, D. Wang (1999)
Apoptosis of circulating lymphocytes induced by whole body gamma-irradiation and its mechanism.Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 18 3
K. Wilkie (2013)
A review of mathematical models of cancer-immune interactions in the context of tumor dormancy.Advances in experimental medicine and biology, 734
R. Weichselbaum, H. Liang, Liufu Deng, yang-xin fu (2017)
Radiotherapy and immunotherapy: a beneficial liaison?Nature Reviews Clinical Oncology, 14
S. Demaria, S. Formenti (2016)
Can abscopal effects of local radiotherapy be predicted by modeling T cell trafficking?Journal for Immunotherapy of Cancer, 4
J. Kao, A. Lavaf, M. Teng, D. Huang, E. Genden (2008)
Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage.International journal of radiation oncology, biology, physics, 71 2
M. Robertson-Tessi, A. El-Kareh, A. Goriely (2012)
A mathematical model of tumor-immune interactions.Journal of theoretical biology, 294
S. Formenti, S. Demaria (2012)
Radiation therapy to convert the tumor into an in situ vaccine.International journal of radiation oncology, biology, physics, 84 4
Roth SL, Audretsch W, Bojar H
Retrospective study of neoadjuvant versus adjuvant radiochemotherapy in locally advanced noninflammatory breast cancer: Survival advantage in cT2 category by neoadjuvant radiochemotherapy
Sofia Gameiro, Momodou Jammeh, Max Wattenberg, K. Tsang, S. Ferrone, J. Hodge (2014)
Abstract 632: Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killingCancer Research, 74
PURPOSE: Early-stage cancers are routinely treated with surgery followed by radiotherapy (SR). Radiotherapy before surgery (RS) has been widely ignored for some cancers. We evaluate overall survival (OS) and disease-free survival (DFS) with SR and RS for different cancer types and simulate the plausibility of RS- and SR-induced antitumor immunity contributing to outcomes. MATERIALS AND METHODS: We analyzed a SEER data set of early-stage cancers treated with SR or RS. OS and DFS were calculated for cancers with sufficient numbers for statistical power (cancers of lung and bronchus, esophagus, rectum, cervix uteri, corpus uteri, and breast). We simulated the immunologic consequences of SR, RS, and radiotherapy alone in a mathematical model of tumor-immune interactions. RESULTS: RS improved OS for cancers with low 20-year survival rates (lung: hazard ratio [HR], 0.88; P = .046) and improved DFS for cancers with higher survival (breast: HR = 0.64; P < .001). For rectal cancer, with intermediate 20-year survival, RS improved both OS (HR = 0.89; P = .006) and DFS (HR = 0.86; P = .04). Model simulations suggested that RS could increase OS by eliminating cancer for a broader range of model parameters and radiotherapy-induced antitumor immunity compared with SR for selected parameter combinations. This could create an immune memory that may explain increased DFS after RS for certain cancers. CONCLUSION: Study results suggest plausibility that radiation to the bulk of the tumor could induce a more robust immune response and better harness the synergy of radiotherapy and antitumor immunity than postsurgical radiation to the tumor bed. This exploratory study provides motivation for prospective evaluation of immune activation of RS versus SR in controlled clinical studies.
JCO Clinical Cancer Informatics – Wolters Kluwer Health
Published: Apr 9, 2019
Keywords: PITX2, SNCG, CFD, TCIRG1
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.